Table 1. Demographic Characteristics of Childhood Cancer Survivors.
| Characteristic | No. (%) (nā=ā121) |
|---|---|
| Current age, median (range), y | 16 (7.0-47.0) |
| Age at diagnosis, median (range), y | 4 (0-17.5) |
| Time since completion of treatment, median (range), y | 8.5 (1.5-29.0) |
| Body mass index, median (range)a | 20.6 (14.2-38.4) |
| Sex | |
| Male | 65 (53.7) |
| Female | 56 (46.3) |
| Type of malignancy | |
| Leukemia | 64 (52.9) |
| Lymphoma | 17 (14) |
| Solid tumor | 36 (29.8) |
| Other | 4 (3.3) |
| Type of chemotherapy | |
| Vinca alkaloid | 86 (71.1) |
| Platinum agent | 7 (5.8) |
| Both | 13 (10.7) |
| Thalidomide | 1 (0.8) |
| None | 14 (11.6) |
| No. of peripheral neurotoxic agents | |
| 1 | 88 (72.7) |
| ā„2 | 19 (15.7) |
| None | 14 (11.6) |
| Radiotherapyb | |
| Yes | 53 (43.8) |
| No | 68 (56.2) |
| Stem cell transplantation | |
| Yes | 31 (25.7) |
| No | 90 (74.4) |
| Dose reduction during treatment attributed to neuropathy | |
| Yes | 7 (5.8) |
| No | 113 (93.4) |
| Unknown | 1 (0.8) |
a
Body mass index calculated as weight in kilograms divided by height in meters squared.
b
Radiotherapy included cranial or craniospinal, extracranial involved-field, and total body irradiation.